• 1
    Pfefferkorn M, Burke G, Griffiths A, et al. Growth abnormalities persist in newly diagnosed children with Crohn disease despite current treatment paradigms. J Pediatr Gastroenterol Nutr. 2009; 48: 168174.
  • 2
    Griffiths AM, Nguyen P, Smith C, et al. Growth and clinical course of children with Crohn's disease. Gut. 1993; 34: 939943.
  • 3
    Sawczenko A, Ballinger AB, Croft NM, et al. Adult height in patients with early onset of Crohn's disease. Gut. 2003; 52: 454455; author reply 455.
  • 4
    Sawczenko A, Ballinger AB, Savage MO, et al. Clinical features affecting final adult height in patients with pediatric-onset Crohn's disease. Pediatrics. 2006; 118: 124129.
  • 5
    Gupta N, Bostrom AG, Kirschner BS, et al. Gender differences in presentation and course of disease in pediatric patients with Crohn disease. Pediatrics. 2007; 120: e14181425.
  • 6
    Denson LA, Menon RK, Shaufl A, et al. TNF-alpha downregulates murine hepatic growth hormone receptor expression by inhibiting Sp1 and Sp3 binding. J Clin Invest. 2001; 107: 14511458.
  • 7
    DiFedele LM, He J, Bonkowski EL, et al. Tumor necrosis factor alpha blockade restores growth hormone signaling in murine colitis. Gastroenterology. 2005; 128: 12781291.
  • 8
    Wang X, Jiang J, Warram J, et al. Endotoxin-induced proteolytic reduction in hepatic growth hormone (GH) receptor: a novel mechanism for GH insensitivity. Mol Endocrinol. 2008; 22: 14271437.
  • 9
    Thayu M, Denson LA, Shults J, et al. Determinants of changes in linear growth and body composition in incident pediatric Crohn's disease. Gastroenterology. 2010; 139: 430438.
  • 10
    Levine A, Shamir R, Wine E, et al. TNF promoter polymorphisms and modulation of growth retardation and disease severity in pediatric Crohn's disease. Am J Gastroenterol. 2005; 100: 15981604.
    Direct Link:
  • 11
    Sawczenko A, Azooz O, Paraszczuk J, et al. Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children. Proc Natl Acad Sci U S A. 2005; 102: 1326013265.
  • 12
    Hildebrand H, Karlberg J, Kristiansson B. Longitudinal growth in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1994; 18: 165173.
  • 13
    Tomer G, Ceballos C, Concepcion E, et al. NOD2/CARD15 variants are associated with lower weight at diagnosis in children with Crohn's disease. Am J Gastroenterol. 2003; 98: 24792484.
    Direct Link:
  • 14
    Wine E, Reif SS, Leshinsky-Silver E, et al. Pediatric Crohn's disease and growth retardation: the role of genotype, phenotype, and disease severity. Pediatrics. 2004; 114: 12811286.
  • 15
    Han X, Uchida K, Jurickova I, et al. Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease. Gastroenterology. 2009; 136: 12611271, e1261–1263.
  • 16
    Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006; 55: 749753.
  • 17
    Uchida K, Nakata K, Trapnell BC, et al. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis. Blood. 2004; 103: 10891098.
  • 18
    Pasternak BA, D'Mello S, Jurickova II, et al. Lipopolysaccharide exposure is linked to activation of the acute phase response and growth failure in pediatric Crohn's disease and murine colitis. Inflamm Bowel Dis. 2010; 16: 856869.
  • 19
    Baumann G. Growth hormone binding protein 2001. J Pediatr Endocrinol Metab. 2001; 14: 355375.
  • 20
    Lee JJ, Escher JC, Shuman MJ, et al. Final adult height of children with inflammatory bowel disease is predicted by parental height and patient minimum height Z-score. Inflamm Bowel Dis. 2010; 16: 16691677.
  • 21
    Nylund C, D'Mello S, Kim MO, et al. Granulocyte-macrophage colony stimulating factor auto-antibodies and increased intestinal permeability in Crohn's disease. J Pediatr Gastroenterol Nutr. 2010; [Epub ahead of print].
  • 22
    Merimee TJ, Russell B, Quinn S, et al. Hormone and receptor studies: relationship to linear growth in childhood and puberty. J Clin Endocrinol Metab. 1991; 73: 10311037.
  • 23
    Postel-Vinay MC, Saab C, Gourmelen M. Nutritional status and growth hormone-binding protein. Horm Res. 1995; 44: 177181.
  • 24
    De Benedetti F, Meazza C, Oliveri M, et al. Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis. Endocrinology. 2001; 142: 48184826.